133 related articles for article (PubMed ID: 8971169)
21. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
22. Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors.
Tang DC; Johnston SA; Carbone DP
Cancer Gene Ther; 1994 Mar; 1(1):15-20. PubMed ID: 7621233
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
[TBL] [Abstract][Full Text] [Related]
24. A glial-specific, repressible, adenovirus vector for brain tumor gene therapy.
Chen J; Bezdek T; Chang J; Kherzai AW; Willingham T; Azzara M; Nisen PD
Cancer Res; 1998 Aug; 58(16):3504-7. PubMed ID: 9721849
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of the human myeloperoxidase promoter region.
Chumakov AM; Chumakova EA; Chih D; Koeffler HP
Int J Oncol; 2000 Feb; 16(2):401-11. PubMed ID: 10639585
[TBL] [Abstract][Full Text] [Related]
26. Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses.
Hurtado Picó A; Wang X; Sipo I; Siemetzki U; Eberle J; Poller W; Fechner H
Mol Ther; 2005 Apr; 11(4):563-77. PubMed ID: 15771959
[TBL] [Abstract][Full Text] [Related]
27. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
[TBL] [Abstract][Full Text] [Related]
28. A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control.
Nettelbeck DM; Jérôme V; Müller R
Gene Ther; 1999 Jul; 6(7):1276-81. PubMed ID: 10455436
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
[TBL] [Abstract][Full Text] [Related]
31. beta-Gal enzyme activity driven by the HSV LAT promoter does not correspond to beta-gal RNA levels in mouse trigeminal ganglia.
Huang QS; Valyi-Nagy T; Kesari S; Fraser NW
Gene Ther; 1997 Aug; 4(8):797-807. PubMed ID: 9338008
[TBL] [Abstract][Full Text] [Related]
32. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.
Drexler I; Antunes E; Schmitz M; Wölfel T; Huber C; Erfle V; Rieber P; Theobald M; Sutter G
Cancer Res; 1999 Oct; 59(19):4955-63. PubMed ID: 10519409
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Yamamoto M; Alvarez RD; Curiel DT
Gene Ther; 2004 Apr; 11(7):645-8. PubMed ID: 15029227
[TBL] [Abstract][Full Text] [Related]
34. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene.
Hughes BW; Wells AH; Bebok Z; Gadi VK; Garver RI; Parker WB; Sorscher EJ
Cancer Res; 1995 Aug; 55(15):3339-45. PubMed ID: 7614469
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors.
Arita E; Kondoh M; Isoda K; Nishimori H; Yoshida T; Mizuguchi H; Yagi K
Eur J Pharm Biopharm; 2008 Sep; 70(1):1-6. PubMed ID: 18468873
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
Frauli M; Ribault S; Neuville P; Augé F; Calenda V
Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
[TBL] [Abstract][Full Text] [Related]
37. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
38. The human cGMP-PDE beta-subunit promoter region directs expression of the gene to mouse photoreceptors.
Ogueta SB; Di Polo A; Flannery JG; Yamashita CK; Farber DB
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4059-63. PubMed ID: 11095595
[TBL] [Abstract][Full Text] [Related]
39. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
40. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.
Yamamura H; Hashio M; Noguchi M; Sugenoya Y; Osakada M; Hirano N; Sasaki Y; Yoden T; Awata N; Araki N; Tatsuta M; Miyatake SI; Takahashi K
Cancer Res; 2001 May; 61(10):3969-77. PubMed ID: 11358814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
